Persistent hypoglycemia as an early, atypical presentation of hepatocellular carcinoma: A case report and systematic review of the literature

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The current study presents a case of persistent hypoglycemia as the initial manifestation of advanced hepatocellular carcinoma (HCC), as well as a systematic review of the management of hypoglycemia associated with HCC. A 42-year-old female presented with loss of consciousness and a blood glucose level of 30 mg/dl (normal range, 80-140 mg/dl). Abdominal ultrasound and computed tomography were performed to investigate tenderness in the right upper quadrant, and the results revealed a hepatic mass of 15 cm in diameter, with metastasis. A diagnosis of insulinoma was ruled out by examining the insulin level. Prednisolone treatment was ineffective for relieving the persistent hypoglycemia, however, a single dose of palliative radiotherapy reduced the hypoglycemic episodes to once monthly. Due to the advanced disease, the patient refused further treatment, with the exception of a palliative therapy with glucose fluid. The patient succumbed to pneumonia with sepsis. A systematic review of the literature indicated that steroids were the most commonly used drug for hypoglycemia associated with HCC, however, in the majority of cases no effect was noted as observed in this study. Cytoreduction by surgery or systemic chemotherapy has been the most effective treatment. Although rare, hypoglycemia may be the initial symptom of HCC. Cytoreduction is the most effective method of treating hypoglycemia associated with HCC.

Original languageEnglish
Pages (from-to)1810-1814
Number of pages5
JournalOncology Letters
Volume8
Issue number4
DOIs
Publication statusPublished - 2014

Fingerprint

Hypoglycemia
Hepatocellular Carcinoma
Insulinoma
Unconsciousness
Prednisolone
Palliative Care
Hypoglycemic Agents
Blood Glucose
Sepsis
Pneumonia
Reference Values
Radiotherapy
Therapeutics
Steroids
Tomography
Insulin
Neoplasm Metastasis
Glucose
Drug Therapy
Liver

Keywords

  • Hepatocellular carcinoma
  • Hypoglycemia
  • Review
  • Signs and symptoms
  • Steroids

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{573db1fbd4884f8086afe77f65889d65,
title = "Persistent hypoglycemia as an early, atypical presentation of hepatocellular carcinoma: A case report and systematic review of the literature",
abstract = "The current study presents a case of persistent hypoglycemia as the initial manifestation of advanced hepatocellular carcinoma (HCC), as well as a systematic review of the management of hypoglycemia associated with HCC. A 42-year-old female presented with loss of consciousness and a blood glucose level of 30 mg/dl (normal range, 80-140 mg/dl). Abdominal ultrasound and computed tomography were performed to investigate tenderness in the right upper quadrant, and the results revealed a hepatic mass of 15 cm in diameter, with metastasis. A diagnosis of insulinoma was ruled out by examining the insulin level. Prednisolone treatment was ineffective for relieving the persistent hypoglycemia, however, a single dose of palliative radiotherapy reduced the hypoglycemic episodes to once monthly. Due to the advanced disease, the patient refused further treatment, with the exception of a palliative therapy with glucose fluid. The patient succumbed to pneumonia with sepsis. A systematic review of the literature indicated that steroids were the most commonly used drug for hypoglycemia associated with HCC, however, in the majority of cases no effect was noted as observed in this study. Cytoreduction by surgery or systemic chemotherapy has been the most effective treatment. Although rare, hypoglycemia may be the initial symptom of HCC. Cytoreduction is the most effective method of treating hypoglycemia associated with HCC.",
keywords = "Hepatocellular carcinoma, Hypoglycemia, Review, Signs and symptoms, Steroids",
author = "Tsai, {Chen Yen} and Chou, {Shou Chu} and Liu, {Hsien Ta} and Lin, {Jiunn Diann} and Ying-Chin Lin",
year = "2014",
doi = "10.3892/ol.2014.2365",
language = "English",
volume = "8",
pages = "1810--1814",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - Persistent hypoglycemia as an early, atypical presentation of hepatocellular carcinoma

T2 - A case report and systematic review of the literature

AU - Tsai, Chen Yen

AU - Chou, Shou Chu

AU - Liu, Hsien Ta

AU - Lin, Jiunn Diann

AU - Lin, Ying-Chin

PY - 2014

Y1 - 2014

N2 - The current study presents a case of persistent hypoglycemia as the initial manifestation of advanced hepatocellular carcinoma (HCC), as well as a systematic review of the management of hypoglycemia associated with HCC. A 42-year-old female presented with loss of consciousness and a blood glucose level of 30 mg/dl (normal range, 80-140 mg/dl). Abdominal ultrasound and computed tomography were performed to investigate tenderness in the right upper quadrant, and the results revealed a hepatic mass of 15 cm in diameter, with metastasis. A diagnosis of insulinoma was ruled out by examining the insulin level. Prednisolone treatment was ineffective for relieving the persistent hypoglycemia, however, a single dose of palliative radiotherapy reduced the hypoglycemic episodes to once monthly. Due to the advanced disease, the patient refused further treatment, with the exception of a palliative therapy with glucose fluid. The patient succumbed to pneumonia with sepsis. A systematic review of the literature indicated that steroids were the most commonly used drug for hypoglycemia associated with HCC, however, in the majority of cases no effect was noted as observed in this study. Cytoreduction by surgery or systemic chemotherapy has been the most effective treatment. Although rare, hypoglycemia may be the initial symptom of HCC. Cytoreduction is the most effective method of treating hypoglycemia associated with HCC.

AB - The current study presents a case of persistent hypoglycemia as the initial manifestation of advanced hepatocellular carcinoma (HCC), as well as a systematic review of the management of hypoglycemia associated with HCC. A 42-year-old female presented with loss of consciousness and a blood glucose level of 30 mg/dl (normal range, 80-140 mg/dl). Abdominal ultrasound and computed tomography were performed to investigate tenderness in the right upper quadrant, and the results revealed a hepatic mass of 15 cm in diameter, with metastasis. A diagnosis of insulinoma was ruled out by examining the insulin level. Prednisolone treatment was ineffective for relieving the persistent hypoglycemia, however, a single dose of palliative radiotherapy reduced the hypoglycemic episodes to once monthly. Due to the advanced disease, the patient refused further treatment, with the exception of a palliative therapy with glucose fluid. The patient succumbed to pneumonia with sepsis. A systematic review of the literature indicated that steroids were the most commonly used drug for hypoglycemia associated with HCC, however, in the majority of cases no effect was noted as observed in this study. Cytoreduction by surgery or systemic chemotherapy has been the most effective treatment. Although rare, hypoglycemia may be the initial symptom of HCC. Cytoreduction is the most effective method of treating hypoglycemia associated with HCC.

KW - Hepatocellular carcinoma

KW - Hypoglycemia

KW - Review

KW - Signs and symptoms

KW - Steroids

UR - http://www.scopus.com/inward/record.url?scp=84940278856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940278856&partnerID=8YFLogxK

U2 - 10.3892/ol.2014.2365

DO - 10.3892/ol.2014.2365

M3 - Article

AN - SCOPUS:84940278856

VL - 8

SP - 1810

EP - 1814

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 4

ER -